SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 43 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $68,600 | -61.0% | 98,000 | -49.8% | 0.00% | – |
Q4 2022 | $175,698 | -19.0% | 195,219 | +438.5% | 0.00% | – |
Q3 2022 | $217,000 | -30.2% | 36,250 | -55.7% | 0.00% | – |
Q1 2022 | $311,000 | -64.0% | 81,739 | -57.4% | 0.00% | – |
Q4 2021 | $864,000 | +94.6% | 192,012 | +101.6% | 0.00% | – |
Q3 2021 | $444,000 | +0.5% | 95,235 | +51.7% | 0.00% | – |
Q2 2021 | $442,000 | +100.9% | 62,792 | +720.8% | 0.00% | – |
Q2 2020 | $220,000 | – | 7,650 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alambic Investment Management, L.P. | 20,711 | $81,000 | 0.89% |
RA Capital Management | 4,681,858 | $18,212,000 | 0.33% |
Ghost Tree Capital, LLC | 200,000 | $778,000 | 0.22% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $7,336,000 | 0.13% |
Virtu Financial LLC | 39,062 | $152,000 | 0.03% |
Quantitative Systematic Strategies LLC | 14,195 | $55,000 | 0.01% |
Cetera Advisor Networks LLC | 85,000 | $331,000 | 0.01% |
BAILARD, INC. | 38,600 | $150,000 | 0.01% |
Chicago Partners Investment Group LLC | 14,081 | $52,000 | 0.01% |
EXANE DERIVATIVES | 4,078 | $15,863,000 | 0.01% |